Lacosamide UCB Europeiska unionen - svenska - EMA (European Medicines Agency)

lacosamide ucb

ucb pharma s.a. - lakosamid - epilepsier, delvis - antiepileptika, - lacosamide ucb är indicerat som monoterapi och som tilläggsbehandling vid behandling av partiella anfall med eller utan sekundär generalisering hos vuxna, ungdomar och barn från 4 års ålder med epilepsi.

Lacosamide Adroiq Europeiska unionen - svenska - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lakosamid - epilepsi - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Lacosamide Accord Europeiska unionen - svenska - EMA (European Medicines Agency)

lacosamide accord

accord healthcare s.l.u. - lakosamid - epilepsi - antiepileptika, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Lacosamide Medical Valley 10 mg/ml Sirap Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide medical valley 10 mg/ml sirap

medical valley invest ab - lakosamid - sirap - 10 mg/ml - metylparahydroxibensoat hjälpämne; glycerol 85% hjälpämne; sorbitol hjälpämne; lakosamid 10 mg aktiv substans

Lacosamide G.L. 50 mg + 100 mg + 150 mg + 200 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide g.l. 50 mg + 100 mg + 150 mg + 200 mg filmdragerad tablett

g.l. pharma gmbh - lakosamid - filmdragerad tablett - 50 mg + 100 mg + 150 mg + 200 mg - lakosamid 200 mg aktiv substans; lakosamid 150 mg aktiv substans; lakosamid 100 mg aktiv substans; lakosamid 50 mg aktiv substans

Lacosamide G.L. 10 mg/ml Infusionsvätska, lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide g.l. 10 mg/ml infusionsvätska, lösning

g.l. pharma gmbh - lakosamid - infusionsvätska, lösning - 10 mg/ml - lakosamid 10 mg aktiv substans

Lacosamide Medical Valley 150 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide medical valley 150 mg filmdragerad tablett

medical valley invest ab - lakosamid - filmdragerad tablett - 150 mg - lakosamid 150 mg aktiv substans

Lacosamide Medical Valley 200 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide medical valley 200 mg filmdragerad tablett

medical valley invest ab - lakosamid - filmdragerad tablett - 200 mg - lakosamid 200 mg aktiv substans

Lacosamide Medical Valley 100 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide medical valley 100 mg filmdragerad tablett

medical valley invest ab - lakosamid - filmdragerad tablett - 100 mg - lakosamid 100 mg aktiv substans

Lacosamide Medical Valley 50 mg Filmdragerad tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

lacosamide medical valley 50 mg filmdragerad tablett

medical valley invest ab - lakosamid - filmdragerad tablett - 50 mg - lakosamid 50 mg aktiv substans